432 related articles for article (PubMed ID: 29409357)
21. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
[TBL] [Abstract][Full Text] [Related]
23. Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations.
Fernandes-Rosa FL; Amar L; Tissier F; Bertherat J; Meatchi T; Zennaro MC; Boulkroun S
Mol Cell Endocrinol; 2015 Jun; 408():220-6. PubMed ID: 25617716
[TBL] [Abstract][Full Text] [Related]
24. Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Pitsava G; Faucz FR; Stratakis CA; Hannah-Shmouni F
Curr Cardiol Rep; 2022 Sep; 24(9):1189-1195. PubMed ID: 35841527
[TBL] [Abstract][Full Text] [Related]
25. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.
Kitamoto T; Suematsu S; Yamazaki Y; Nakamura Y; Sasano H; Matsuzawa Y; Saito J; Omura M; Nishikawa T
J Clin Endocrinol Metab; 2016 Feb; 101(2):494-503. PubMed ID: 26606680
[TBL] [Abstract][Full Text] [Related]
27. Clinical Translationality of
Kitamoto T; Nishikawa T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012306
[TBL] [Abstract][Full Text] [Related]
28. KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
Zhang C; Wu L; Jiang L; Su T; Zhou W; Zhong X; Xie J; Sun F; Zhu Y; Jiang Y; Wang W
Endocr Pract; 2021 Jul; 27(7):736-742. PubMed ID: 33678553
[TBL] [Abstract][Full Text] [Related]
29. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
Tauber P; Penton D; Stindl J; Humberg E; Tegtmeier I; Sterner C; Beuschlein F; Reincke M; Barhanin J; Bandulik S; Warth R
Endocrinology; 2014 Apr; 155(4):1353-62. PubMed ID: 24506072
[TBL] [Abstract][Full Text] [Related]
31. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
Chen YJ; Peng KY; Chueh JS; Liao HW; Hsieh TY; Wu VC; Wang SM
Front Endocrinol (Lausanne); 2022; 13():816754. PubMed ID: 35399924
[TBL] [Abstract][Full Text] [Related]
32. Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
Chen KM; Chang YL; Wu TH; Lee BC; Chen PT; Liu KL; Hong JS; Chang CC; Wu VC; Lin YH;
J Hypertens; 2021 Dec; 39(12):2353-2360. PubMed ID: 34313632
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.
Wu VC; Huang KH; Peng KY; Tsai YC; Wu CH; Wang SM; Yang SY; Lin LY; Chang CC; Lin YH; Lin SL; Chu TS; Wu KD
Sci Rep; 2015 Jun; 5():11396. PubMed ID: 26066391
[TBL] [Abstract][Full Text] [Related]
34. [Primary aldosteronism: new insights into familial forms].
van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
[TBL] [Abstract][Full Text] [Related]
35.
Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
[TBL] [Abstract][Full Text] [Related]
36. Urine steroid metabolomics as a diagnostic tool in primary aldosteronism.
Prete A; Lang K; Pavlov D; Rhayem Y; Sitch AJ; Franke AS; Gilligan LC; Shackleton CHL; Hahner S; Quinkler M; Dekkers T; Deinum J; Reincke M; Beuschlein F; Biehl M; Arlt W
J Steroid Biochem Mol Biol; 2024 Mar; 237():106445. PubMed ID: 38104729
[TBL] [Abstract][Full Text] [Related]
37. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
38. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel
Tan GC; Negro G; Pinggera A; Tizen Laim NMS; Mohamed Rose I; Ceral J; Ryska A; Chin LK; Kamaruddin NA; Mohd Mokhtar N; A Jamal AR; Sukor N; Solar M; Striessnig J; Brown MJ; Azizan EA
Hypertension; 2017 Jul; 70(1):129-136. PubMed ID: 28584016
[TBL] [Abstract][Full Text] [Related]
39. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract][Full Text] [Related]
40. Primary aldosteronism caused by a pI157S somatic
Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
